| INTRODUCTION
Influenza virus infection causes a range of illness from mild to severe disease and death, with the highest rates of morbidity and mortality among the very young and very old. [1] [2] [3] Vaccination against influenza is the best way to prevent influenza-related morbidity and mortality. 4 Large population studies may be needed to evaluate vaccine effectiveness and to conduct influenza surveillance. 5 However, the need to collect timely diagnostic samples during acute illness periods at a reasonable cost may be challenging in such studies. Self-collection of nasal swabs may be one method to improve the detection of influenza cases in a timely and cost-effective manner for epidemiologic studies and surveillance.
Self-collection of nasal swabs involves provision of a swab kit to participants to be used at home to swab the anterior nares within 2-3 days of developing an acute respiratory infection (ARI) when influenza virus is present at the highest concentration. 6 After collection, swabs may be returned to study staff by mail, dropped off or collected at home by study staff. Several studies have shown self-collection of nasal swabs among adults to be a feasible and reliable method for ARI surveillance. 5, [7] [8] [9] The Flu Watch Cohort Study followed community cohorts in England over six successive influenza seasons and successfully obtained diagnostic nasal specimens through self-collection of nasal swabs for more than 85% of ARI episodes. 5 Additionally, a recent study among Swedish adults used nasal self-swab samples mailed in by participants for virus detection and found that the influenzapositive test results could be used to measure influenza seasonality. 7 However, to our knowledge, there has not yet been a specific evaluation of self-collection of nasal swabs by older adults, who may have reduced mobility and cognitive function that could limit their ability to collect valid nasal swabs. 10 Effectiveness of the influenza vaccine in preventing influenza-related morbidity in older adults rarely has been measured in Thailand, and only once against laboratory-confirmed influenza. 11, 12 In preparation for a cohort study of the effectiveness of the inactivated influenza vaccine to prevent influenza-associated morbidity among persons >65 years in Thailand, we conducted a pilot study to determine the acceptability, adequacy, timeliness, and validity of self-collected nasal swabs.
| METHODS
Our evaluation consisted of two parts: a community study to evaluate the acceptability, timeliness, and the adequacy of samples collected by community-dwelling persons >65 years; and a clinic study to evaluate the acceptability of self-swabbing, and the sensitivity and specificity of self-collected nasal swabs for influenza virus detection compared to samples collected by healthcare workers (HCW).
| Community study
The community study was conducted in one subdistrict of Nakhon Phanom Province. We took a systematic, random sample of persons >65 years using a list of all residents >65 years derived from a community census that was updated just prior to sampling. 
| Clinic study
The clinic study was conducted between February and December 2015 at four outpatient clinics in Nakhon Phanom Province among persons >65 years old seeking medical attention for an ARI, defined as having two or more of the following symptoms starting within the last seven days: cough or worsening of a chronic cough, measured (axillary temperature ≥38.5°C) or subjective fever, nasal congestion, and sore throat. The ARI case definition for the clinic was constructed to maximize the likelihood that the ARI was caused by influenza, whereas the ARI case definition for the community was designed to increase the chances of an ARI event to trigger self-collection of a nasal swab. Individuals were eligible for enrollment if they were a resident of Nakhon Phanom and excluded if they were unable to communicate or understand instructions, prone to nose bleeds, or presented with severe illness that needed urgent medical attention.
Patients who participated in the community study were not eligible for the clinic study.
Patients presenting to the outpatient department were screened for respiratory-related symptoms and invited to enroll if they met eli- 
| Outcomes acceptability, adequacy, feasibility, timeliness, and validity
Participants in both studies were interviewed by trained study staff after a nasal specimen was obtained to determine acceptability of self-collection of nasal swabs based on self-report. Participants in the clinic study additionally were asked to evaluate the acceptability of swabbing by HCWs. Questions were designed to determine participants' ease and comfort level in collecting a nasal swab, their understanding of instructions, and general acceptability of self-collection of nasal swabs. Participants rated each item on a three-point scale as disagree, neutral, or agree.
The adequacy of self-collected nasal swabs was evaluated among participants of the community study who reported an ARI during the one-month observation period. An adequate sample was defined as:
a nasal swab self-collected within 72 hours of symptom onset, refrigerated after collection in a capped tube with UTM until retrieved by study staff, and testing positive for ribonuclease P (Rnase P), an indicator of the presence of human cells. 13 A sample was positive for Rnase P if the cycle threshold (Ct) value from real-time reverse transcriptase polymerase chain reaction (rRT-PCR) test was <37.
The sensitivity and specificity of self-collected nasal swabs for detection of influenza virus were measured in the clinic study among outpatients presenting with ARI.
| Sample size
For the community study, we calculated a sample size of 150 persons >65 years old to measure the proportion who could produce an adequate nasal swab with a precision of +/− five percentage points, assuming a proportion of 90%, a Type I error rate of 5% and a combined refusal and dropout rate of 10%. For the clinic study, we calculated that a sample size of 19 ARI patients positive for influenza virus and 35 patients negative for influenza virus were needed, assuming a sensitivity of 95%, specificity of 90%, precision of +/− 10 percentage points, and a 5% Type I error rate.
| Storage and laboratory analysis
In the community study, specimens were stored in participants' own or a neighbor's refrigerator for less than 24 hours until they were collected by study staff with cool boxes at 2-8°C. Both community and clinic samples were stored at 2-8°C in a refrigerator at a centralized clinic, with storage temperatures monitored daily. In less than 24 hours, all the samples in the clinic refrigerator were placed into liquid nitrogen tanks. Samples were sent on liquid nitrogen weekly to the Thai National Institute of Health (NIH) for rRT-PCR analysis. All specimens were tested by rRT-PCR for the presence of Rnase P.
14 Clinic specimens were also tested for influenza A and B viruses using standard protocols and Ct values from rRT-PCR were recorded. 
| Human subjects
Written consent was obtained from all participants prior to enroll- 
| RESULTS

| Participant characteristics
Of the 150 participants selected for the community study, we enrolled 108 (72%; 12 could not be found, 26 met one or more exclusion criteria, and four declined to participate). Participants in the community study had a mean age of 73 years (range 65-91; Table 1 ), 59 (55%)
were female, 54 (50%) currently lived with a spouse, and 15 (14%) had received education past primary school. Participants in the community study experienced 26 (24%) cases of ARI within the 1 month period.
There were 127 participants enrolled in the clinic study with a mean age of 73 years (range 65-95; Table 1 ). Among the clinic participants, 124 (98%) experienced cough. Fever, nasal congestion, and sore throat were also common. Clinic visits and sample collection occurred <72 hours, 3-4 days, and >5 days from symptom onset for 57 (45%), 37 (29%), and 33 (26%) of the participants, respectively.
| Acceptability of self-collected nasal samples
Among all participants in both studies, 232 (99%) found self-collection of nasal swabs acceptable and 229 (97%) agreed that self-collection of nasal swabs was easy to perform (Table 2 ). There were 38 (16%) participants who felt uncomfortable taking the swab themselves and 26 (11%) who found the instructions confusing. In the clinic study, the proportion of participants who felt uncomfortable when a HCW took either a nasal or NP swab (34, 27%) was higher than the proportion who felt uncomfortable when they self-swabbed (22, 17%; P<.001).
| Adequacy of self-collected nasal samples
Among the 26 ARI samples collected from community participants, 24
(92%) were considered adequate samples; 26 (100%) samples were collected within 72 hours of symptom onset, 26 (100%) met storage criteria, and 24 (92%) tested positive for Rnase P. There were 82 persons who took self-collected nasal swabs at the end of the study, and 81 (99%) tested positive for Rnase P. In the clinic study, 127 (100%) samples had adequate levels of Rnase P, and the mean Ct values for Rnase P in self-collected nasal swabs and HCW-collected nasal swabs were similar (29.50 and 29.08, respectively; P=.06).
| Sensitivity and specificity of nasal self-swab samples to detect influenza virus
A total of 9 (15%) influenza virus infections were detected among 127 participants of the clinic study; 6 (10%) had influenza A (H3N2) and The sensitivity of self-collected nasal swabs compared to HCWcollected NP swabs was 78% (95% confidence interval [CI], 40-97) and the specificity was 100% (95% CI, 97-100; Table 3 ). The sensitivity of self-collected nasal swabs compared to HCW nasal swabs was 88%
(95% CI, 47-100), and the specificity was 100% (95% CI, 97-100). The Rnase P Ct values for the two self-collected nasal swab samples discordant for influenza virus with the HCW-collected NP swabs were higher (indicating a lower quantity of human cells) than for the NP samples (Table 4) . Similarly, the sample that was discordant for influenza virus between HCW-collected NP and HCW-collected nasal swab had a higher Rnase P Ct value in the sample negative for influenza virus. The two discordant samples were both collected on the third day after symptom onset.
T A B L E 2 Acceptability of nasal swabbing as reported by participants
| DISCUSSION
We found self-collection of nasal swabs to be highly acceptable to adults >65 years in Thailand and most (92%) were able to take and store an adequate sample. Timeliness of sample collection relative to symptom onset was better with self-collection of nasal swabs than with samples collected from persons with ARI seeking medical attention. In the community study, which we believe represents results that could be expected from research or surveillance studies using selfcollection of nasal swabs, 100% of nasal swabs were self-collected within 72 hours of symptom onset, compared to results from the clinic study, which is more typical of facility-based surveillance, in which only 45% of patients presented within 72 hours of symptom onset.
Two previous studies that investigated the acceptability of nasal self-collection of nasal swabs for detection of viral pathogens among adults between 18 and 69 years of age in Germany showed similar rates of acceptability, ease of self-collection of nasal swabs, and comfort level as we found in this evaluation. 8, 16 In Smieja et al.
17
, asymptomatic adults were asked to take two self-collected nasal swabs and the authors found that 87% and 98% of first and second self-collected nasal swabs, respectively, had adequate cell counts (defined as >25 cells/high powered field). Akmatov et al. 16 found that the mean β-actin DNA concentration (a proxy for the presence of human epithelial cells) was higher among self-collected nasal swabs than healthcare workercollected swabs, indicating that self-collected swabs were adequate for detection of influenza. T A B L E 4 Comparison of ribonuclease P cycle threshold (Rnase P Ct) values for two samples discordant for influenza virus between sample types to measure sensitivity and specificity precisely or to stratify results by influenza type/subtype. Our study was not able to enroll all eligible individuals who presented to the clinic with ARI due to resource limitations, although we do not believe convenience sampling introduced a systematic enrollment bias.
Although self-collected nasal swabs detected fewer influenza virus infections than HCW-collected samples, we believe that the increased ease and acceptability of self-collected nasal swabs will overcome sensitivity limitations to make self-collection of nasal swabs a preferred method for influenza detection in community studies of older adults in Thailand. Reduced diagnostic sensitivity should be incorporated into sample size calculations to insure adequate power. Acceptability and feasibility of using self-collected nasal swabs in other populations should be evaluated. In conclusion, self-collection of nasal swabs could improve the timeliness of sample collection in population-based surveillance and research for influenza among older adults in Thailand.
